Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

A Synthetic Chloride Channel Relaxes Airway Smooth Muscle of the Rat

  • Kwok-hei Yau,

    Affiliation Morningside Laboratory for Chemical Biology, Department of Chemistry, Faculty of Science, The University of Hong Kong, Hong Kong SAR, China

  • Judith Choi-wo Mak,

    Affiliations Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

  • Susan Wai-sum Leung,

    Affiliation Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

  • Dan Yang,

    Affiliation Morningside Laboratory for Chemical Biology, Department of Chemistry, Faculty of Science, The University of Hong Kong, Hong Kong SAR, China

  • Paul M. Vanhoutte

    vanhoutte.hku@hku.hk

    Affiliation Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

A Synthetic Chloride Channel Relaxes Airway Smooth Muscle of the Rat

  • Kwok-hei Yau, 
  • Judith Choi-wo Mak, 
  • Susan Wai-sum Leung, 
  • Dan Yang, 
  • Paul M. Vanhoutte
PLOS
x

Abstract

Synthetic ion channels may have potential therapeutic applications, provided they possess appropriate biological activities. The present study was designed to examine the ability of small molecule-based synthetic Cl channels to modulate airway smooth muscle responsiveness. Changes in isometric tension were measured in rat tracheal rings. Relaxations to the synthetic chloride channel SCC-1 were obtained during sustained contractions to KCl. The anion dependency of the effect of SCC-1 was evaluated by ion substitution experiments. The sensitivity to conventional Cl transport inhibitors was also tested. SCC-1 caused concentration-dependent relaxations during sustained contractions to potassium chloride. This relaxing effect was dependent on the presence of extracellular Cl and HCO3. It was insensitive to conventional Cl channels/transport inhibitors that blocked the cystic fibrosis transmembrane conductance regulator and calcium-activated Cl channels. SCC-1 did not inhibit contractions induced by carbachol, endothelin-1, 5-hydroxytryptamine or the calcium ionophore A23187. SCC-1 relaxes airway smooth muscle during contractions evoked by depolarizing solutions. The Cl conductance conferred by this synthetic compound is distinct from the endogenous transport systems for chloride anions.

Introduction

Synthetic ion channels are of interest because of their potential therapeutic and research applications. Although several synthetic ion channels have been synthesized and characterized [1][4], little information is available concerning their biological effects. Indeed, most of the characterization were carried out on abiotic systems. Typically, ion transport activities were studied using liposome-based fluorescence assays and channel activities were documented in planar lipid bilayer experiments [2]. Whether ion transport activity observed in these systems can be extrapolated to biological systems is, however, uncertain. A few studies have demonstrated the abilities of synthetic ion channels to kill bacteria [5][8] and to induce epithelial chloride (Cl) secretion [9][12]. The action of synthetic ion channels on other biological systems, however, remains elusive. Previous studies have demonstrated the abilities of a small molecule-based synthetic Cl channel assemblage [13] to alter membrane potential, the intracellular calcium concentration ([Ca2+]i) and the contraction level in cultured vascular smooth muscle cells [14].

Ligand-gated Cl channels, γ-aminobutyric acid type A (GABAA) receptor, have been detected in both human and guinea pig airway smooth muscles [15]. In both guinea pig and human trachea, selective activation of these receptors in vitro reduces agonist-induced contractions [15], [16] and potentiates isoproterenol-mediated relaxation [16]. In vivo, selective GABAA agonists attenuate agonist-induced airway constriction when central parasympathetic, postganglionic sympathetic, and inhibitory nonadrenergic, noncholinergic (NANC) neural contributions to airway tone are eliminated, suggesting a direct effect on the airway smooth muscle GABAA receptor [17]. In addition, glycine-activated Cl channel (GlyR) are expressed in guinea pig and human airway smooth muscle [18]. Like that of GABAA receptors, activation of GlyR relaxes agonist-contracted isolated airway smooth muscle and potentiates isoproterenol-mediated relaxation [18]. These observations prompted the investigation of biological activity of synthetic Cl channels in airway smooth muscle. Thus, the present study was designed to examine the effect of SCC-1 [a synthetic molecule-derived ion channel, designed in the laboratory [13], Fig. 1] on the responsiveness of the isolated trachea of the rat.

Results

SCC-1 Relaxed High-K+-induced Airway Smooth Muscles Contraction

Addition of SCC-1 relaxed tracheal rings contracted with 60 mM KCl (Fig. 2A). This relaxation was concentration-dependent and when the SCC-1 concentration in the bath reached 3×10−5 M, the tension returned to the baseline level. Treating the tissues with muscarinic receptor antagonist atropine (10−6 M) did not affect the relaxing effects of SCC-1 (Fig. 2A). The KCl-induced contraction was attenuated significantly by atropine (see Fig. S1).

thumbnail
Figure 2. Effect of SCC-1 on high-K+-induced airway smooth muscle contraction.

A) Concentration-response curves for the relaxant effect of SCC-1 on the rat tracheal rings contracted by 60 mM KCl in the absence (▪) or presence (□) of atropine (10−6 M). B) Concentration-response curves for the relaxing effect of SCC-1 in the rat tracheal rings contracted by 60 mM KCl (▪), high-K+ solution (•) and high-K+-Cl-free solution (▽), high-K+-Cl−/HCO3-free solution (△). */#p<0.05, **/##p<0.01, ***/###/+++p<0.0001, two-way ANOVA followed by Bonferroni post hoc test. *, high-K+ versus high-K+-Cl-free solution. #, 60 mM KCl versus high-K+-Cl-free solution, +, high-K+-Cl−/HCO3-free solution versus all groups. C) In the presence of 3×10−5 M of SCC-1 addition of 60 mM KCl to the organ chamber containing high-K+-Cl−/HCO3-free solution caused relaxation of airway smooth muscles. ***p<0.0001, one-way ANOVA followed by Dunnett’s post hoc test. Data are presented as mean ± SEM, n = 4.

https://doi.org/10.1371/journal.pone.0045340.g002

Since the addition of KCl raised the osmolarity of the bath solution, whether this hyperosmolarity influenced the activity of SCC-1 was in question. The problem was addressed by monitoring the effect of SCC-1 on preparations contracted with iso-osmotic high-K+ solution and compared it to the hyperosmotic situation. The relaxing effects of SCC-1 were not significantly different in both cases (Fig. 2B). To investigate the Cl dependence of the action of SCC-1, high-K+-Cl-free solution was used to obtain the background contraction. In the absence of extracellular Cl, the effect of SCC-1 was attenuated significantly (Fig. 2B). In addition, the relaxing effect of SCC-1 on tracheae contracted by high-K+-Cl−/HCO3-free solution was abolished (Fig. 2B). However, without washing out SCC-1, the addition of 60 mM KCl to the organ chamber in the presence of high-K+-Cl−/HCO3-free solution caused relaxation (Fig. 2C).

Alternatively, the effect of SCC-1 was assessed by treating the tissues prior to the cumulative addition of KCl. At 10−6 M, SCC-1 did not significantly affect the EC50 (Fig. 3A; vehicle control: 32.59±0.92 mM versus SCC-1∶29.54±1.415 mM; p = 0.12) but reduced the maximal contractile effect of KCl (vehicle control: 125.7±2.54% versus SCC-1∶112.9±2.28%; p<0.01). In the presence of SCC-1 (5×10−6 M), the maximal contraction evoked by KCl was reduced significantly (Fig. 3B; vehicle control: 118±2.77% versus SCC-1∶69.63±3.04%; p<0.0001) whereas the EC50 values were not altered significantly (vehicle control: 37.68±2.05 mM versus SCC-1∶36.18±1.33 mM; p = 0.55). The inhibitory effects on KCl-evoked contraction were more pronounced at 5×10−6 M than at 10−6 M.

thumbnail
Figure 3. Contractile responses of isolated rat trachea rings to 60 mM KCl in the absence (▪) or presence (□) of SCC-1 (A an B, 1 and 5×10−6 M respectively).

Contractions are expressed as a percentage of the response to 60 mM KCl. Data are presented as mean ± SEM, n = 4. *p<0.05, **p<0.01, Student’s t-test.

https://doi.org/10.1371/journal.pone.0045340.g003

Cl Transport Inhibitors

The effects of three conventional Cl transport inhibitors, NPPB, DIDS and CFTRinh-172, on KCl-induced contraction were tested. NPPB (5×10−5 and 10−4 M) abolished KCl-induced contractions (see Fig. S2), preventing the use of that drug for further experiments. CFTRinh-172 at 10−5 M caused a modest but significant inhibition of the KCl-induced contraction, while DIDS at 10−4 M did not affect the response (see Fig. S2). At 10−5 M, CFTRinh-172 did not affect the relaxations to SCC-1, whereas DIDS (10−4 M) slightly but significantly reduced its effect at 3×10−5 M (Fig. 4A and 4B).

thumbnail
Figure 4. Concentration-response curves for the relaxing effect of SCC-1 (A and B) on the rat tracheal rings contracted by 60 mM KCl in the absence (▪) or presence (□) of Cl-transport inhibitors.

Data are presented as mean ± SEM, n = 4. **p<0.01, Student’s t-test.

https://doi.org/10.1371/journal.pone.0045340.g004

Carbachol-, Endothelin-1-, 5-hydroxytryptamine- and A23187

Contractions to either carbachol (10−6 M) or endothelin-1 (10−7 M) were not significantly influenced by the cumulative addition of SCC-1 (10−6−3×10−5 M) to the bath solution (Fig. 5A and 5B). Treating the tracheal rings with SCC-1 at 10−5 M had no effect on subsequent contractions evoked by 5-hydroxytryptamine or A23187 (both at 10−6 M) (Fig. 5C and 5D). The preparations did not contract in response to bradykinin, tachykinins or histamine (see Fig. S3) and therefore the effect of SCC-1 on the response to these agonists could not be evaluated.

thumbnail
Figure 5. Effects of SCC-1 on contractions to carbachol (A), endothelin-1 (B), 5-HT (C) and A23187 (D).

As both carbachol and endothelin-1 produced sustained contraction, SCC-1 was added to the bath in cumulative fashion when the plateau was reached. On the other hand, 5-hydroxytryptamine and A23187 induced transient contraction. The effect of the compounds were studied by incubating the tissues with SCC-1 (10−5 M) and the contraction evoked by 5- hydroxytryptamine and A23187 (both at 10−6 M) was subsequently monitored. Contractions are expressed as percentage of the response to 60 mM KCl. Data are presented as mean ± SEM, n = 4.

https://doi.org/10.1371/journal.pone.0045340.g005

Discussion

The present study demonstrates that SCC-1 relaxes contractions of airway smooth muscle to high potassium in a Cl-dependent manner. By contrast, contractions elicited by carbachol, endothelin-1, 5-hydroxytryptamine and A23187 are not affected by the synthetic Cl channel.

The effects of SCC-1 on the contraction of the trachea to high potassium are reminiscent of the observations in vascular smooth muscle [14]. Presumably, the relaxant effects of SCC-1 are related to their ability to form artificial Cl channels in cell membranes, which provide routes for transmembrane Cl movement [13]. The direction of Cl movement is dictated by the relative magnitude of membrane potential and the reversal potential for Cl. Under the depolarizing conditions conferred by high-K+ -solution, the membrane potential is more positive than the reversal potential for Cl [19], and Cl channel formation would lead to Cl influx and hence membrane hyperpolarization. This clamps the membrane potential at a value more negative than the activation threshold for L-type Ca2+ channels [20], thereby limiting voltage-dependent Ca2+ influx and hence inhibition of KCl-induced contraction. Consistent with this interpretation, SCC-1 failed to relax contractions induced by the calcium ionophore A23187, suggesting that increases in [Ca2+]i that is independent of activation of L-type Ca2+ channels were not affected. This latter finding also indicates that SCC-1 does not affect intracellular signaling downstream of the increased [Ca2+]i leading to activation of the contractile proteins. As such, it is likely that SCC-1 relaxed the KCl-contracted airway smooth muscles by causing membrane hyperpolarization and deactivating L-type Ca2+ channels.

The present study demonstrated that KCl-induced contractions consisted in part of an atropine-sensitive cholinergic component and an atropine-resistant component attributed to direct Ca2+ influx via L-type Ca2+ channels. The full relaxation caused by SCC-1 implies that the synthetic compound may also antagonize the cholinergic component, which involves the release of acetylcholine by the presynaptic terminals, a process depending on Ca2+ influx via voltage-gated Ca2+ channels [21], followed by activation of postjunctional muscarinic M3 receptor [22]. As acetylcholine-induced contractions of airway smooth muscle are not blocked by L-type Ca2+ channels blocker [23], SCC-1 may affect the cholinergic component by inhibiting acetylcholine release from nerve terminals rather than by inhibiting the signaling pathway downstream of acetylcholine release. This interpretation was supported by the observation that SCC-1 did not affect carbachol-induced M3 receptor-mediated contraction.

The present study demonstrated that the effects of SCC-1 were independent of hyperosmolarity and the “high-Cl-” condition caused by the addition of KCl to the bath. The presence of extracellular Cl was important for the activities of SCC-1 as indicated by the findings that: 1) eliminating Cl in the bath solution significantly attenuated the relaxing effects of SCC-1 and 2) while the latter failed to relax preparations contracted by high-K+-Cl−/HCO3-free solution, the relaxing effect was restored after addition of 60 mM KCl. Moreover, the residual relaxing effects of SCC-1 during contractions to high-K+-Cl-free solution were eliminated when HCO3 was removed, suggesting that HCO3 transport may also be involved in the actions of SCC-1. Likewise, CFTR, a natural Cl channel, has been suggested to increase HCO3 permeability at low extracellular Cl levels [24] and to serve as HCO3 channel [25].

The Cl conductance conferred by SCC-1 may be novel as its effects were insensitive to both CFTRinh-172 and DIDS, the conventional inhibitors of CFTR [26] and most non-CFTR Cl channels [27], respectively. In an earlier study, CFTRinh-172 and another Cl transport inhibitor DPC also did not affect the ability of SCC-1 to alter the membrane potential in Madin-Darby canine kidney (MDCK) cells [14]. Taken in conjunction, these findings suggest that SCC-1 forms synthetic Cl channels in the cell membranes of airway smooth muscle.

SCC-1 also failed to inhibit contractions elicited by carbachol, endothelin-1 and 5-hydroxytryptamine. These contractile agonists activate Gq-coupled receptors, leading to the generation of multiple secondary messengers, including IP3 (which releases Ca2+ from intracellular stores), diacylglycerol, and activation of multiple Ca2+ channel types [28]. Bronchoconstrictors depolarize airway smooth muscle membrane [29][31], primarily by activation of Cl and non-selective cation currents as well as suppression of K+ currents [30], [31]. However, whether or not agonist-evoked contraction depends on Ca2+ influx via L-type Ca2+ channels remains controversial [32]. Indeed, some studies show that agonist-induced contraction of airway smooth muscles are not affected by L-type Ca2+ channels blockers [29], [33]. When the membrane potential was clamped at negative values below the activation threshold (–40 to –30 mV) for L-type Ca2+ channels, agonist-induced contractions are still observed [34]. Moreover, the normal range of membrane potentials (–70 to –30 mV) observed in airway smooth muscles [32], [35][40] is presumably too negative to activate L-type Ca2+ channels (−20 to +30 mV) [32], [41][44] and even at agonist concentrations reaching maximal contractile effects, the membrane potential is at a level that can only marginally activate L-type Ca2+ channels [32]. These studies prompt the suggestion that agonist stimulation is incapable of depolarizing the membrane to an extent that is sufficient to trigger significant voltage-dependent Ca2+ influx in airway smooth muscles. This conclusion is supported by the clinical findings that L-type Ca2+ channel blockers are relatively ineffective against asthma [45], [46]. If agonist-induced contractions of airway smooth muscle do not rely on voltage-dependent Ca2+ influx, modulation of voltage-dependent Ca2+ influx by synthetic Cl channels should not inhibit them.

In conclusion, the present study demonstrates the ability of SCC-1 to relax contracted airway smooth muscle. This relaxing effect partially depends on extracellular Cl, consistent with the postulated Cl channel function conferred by SCC-1. The synthetic molecule-derived Cl conductance is novel because it is not inhibited by conventional Cl transport inhibitors. On the other hand, SCC-1 does not prevent agonist-induced contractions, which is explained by the voltage-independent nature of these responses.

Materials and Methods

Ethics Statement, Tissue Preparation and Isometric Tension Measurement

This investigation was approved by the Committee on the Use of Laboratory Animals for Teaching and Research of the University of Hong Kong. Adult male 12-weeks-old Sprague-Dawley rats (300–400 g) were maintained under a 12-h light/dark cycle at 21±1°C and were fed with standard laboratory chow (LabDiet 5053, USA) and tap water ad libitum. After being euthanized with pentobarbital sodium (70 mg/ml/kg, i.p.), their chest cavity was opened, and the lungs were removed en bloc and placed immediately into cold oxygenated Krebs-Henseleit solution of the following composition: 120 mM NaCl, 25 mM NaHCO3, 5.5 mM glucose, 4.76 mM KCl, 1.18 mM MgSO4·7H2O, 1.18 mM NaH2PO4·2H2O and 1.25 mM CaCl2·2H2O (control solution). The trachea was dissected free of connective tissues and fat and cut into rings (2–3 mm width). The rings were suspended between two stainless steel hooks in organ chambers filled with 5 mL of control solution. One of the hooks was attached to the organ chamber and the other was connected to a force transducer (AD Instruments, model MLT0201/D, Bella Vista, Australia) for isometric force recording. The bathing solution was maintained at 37°C and continuously aerated with a mixture of 95% O2 and 5% CO2. The rings were allowed to equilibrate under 1 g of tension for 60 min with bathing solution changes every 15 min. During the equilibration, the tension was adjusted to 1 g, except for the last 30 min.

High-K+ (64.76 mM K+) solution was prepared by iso-osmotic replacement of NaCl with equimolar amounts of KCl. For the high-K+-Clfree solution, equimolar Na-gluconate replaced NaCl, K-gluconate replaced KCl and 5 mM Ca-gluconate replaced CaCl2. Calcium was increased to 5 mM to compensate for the Ca2+- buffering capacity of gluconate. The high-K+-Cl−/HCO3-free solution has the following composition: 60 mM Na-gluconate, 64.76 mM K-gluconate, 20 mM Ca-gluconate, 19.5 mM D-mannitol, 5.5 mM glucose, 1.18 mM MgSO4·7H2O, 1.18 mM NaH2PO4·2H2O, 5.6 mM tris and 10 mM HEPES. The solution was gassed with 100% O2.

Effect of SCC-1 on Contractions

Each tracheal ring was contracted with the agonist at the indicated concentration and was allowed to achieve a steady-state plateau. SCC-1 was then added to the bath in a cumulative fashion (10−6–3×10−5 M). This protocol was used for contractile agents that induced sustained contraction, namely, KCl, high-K+ solution, high-K+-Cl-free solution, high-K+-Cl−/HCO3-free solution, carbachol and endothelin-1. For the contraction induced by high-K+-Cl−/HCO3-free solution, when the SCC-1 concentration in the bath reached 3×10−5 M and a steady-state response was obtained, 60 mM KCl was added to the baths to test the Cl-dependency of the effects of SCC-1.

Alternatively, the effect of the synthetic ion channels was determined by adding a single concentration of the compound to the organ chamber 30 min before the addition of contractile agonists and observing how the airway smooth muscle contractility was altered. In this case, the concentration of the tested compound was maintained throughout the experiment. This protocol was primarily used for agonists that induced transient contraction, namely 5-hydroxytryptamine and A23187.

Cl Transport Inhibitors

The effect of Cl transport inhibitors (10−5 M CFTRinh-172, 10−4 M DIDS, 5×10−5 and 10−4 M NPPB) on KCl-evoked contraction was evaluated by adding the inhibitors at the indicated concentrations to the bath 30 min before the addition of 60 mM KCl and observing how the responsiveness of the airway smooth muscle was altered. The inhibitor concentration was maintained throughout the experiment. When steady-state contraction was achieved, SCC-1 was added to the organ chamber in a cumulative fashion (10−6–3×10−5 M).

Chemicals and Drugs

4,4′-Diisothiocyanato-stilbene-2,2′-disulphonic acid (DIDS), 5-hydroxytryptamine (5-HT), the calcium ionophore A23187, carbachol and endothelin-1 were purchased from Sigma Chemicals Co. (St. Louis, MO, USA); CFTRinh-172 from Calbiochem (San Diego, CA, USA) and atropine sulfate from Merck (Darmstadt, Germany). Stock solutions of N1,N3-bis((R)-1-(isobutylamino)-4-methyl-1-oxopentan-2-yloxy)isophthalamide, or SSC-1 (synthesized in the laboratory, Fig. 1), A23187, CFTRinh-172 and DIDS stock were prepared in dimethylsulfoxide (DMSO) while all stock solutions of the remaining drugs were dissolved in de-ionized water.

Data and Statistical Analysis

Data are presented as means ± standard error of the means (SEM), and n indicates the number of rats used in the experiments. Changes in tension were expressed as a percentage of the reference contraction in response to the addition of KCl (60 mM). Relaxation to SCC-1 was expressed as percent reduction of active force (the difference between baseline tension and peak tension generated by contractile agonists). For concentration-response studies, the data were fit by non-linear regression analysis where appropriate. Maximal contractions and EC50 (the concentration of agonist required to produce 50% of the maximal response) were determined. Statistical analysis was performed using two-tailed unpaired Student’s t-tests or ANOVA followed by Bonferroni’s or Dunnett’s post hoc comparison as appropriate. All statistical procedures were computed using Prism version 5.01 (GraphPad Software, San Diego, CA, USA). P-values less than 0.05 were considered to indicate statistically significant differences.

Supporting Information

Figure S1.

Contractile responses of isolated rat trachea rings to KCl (A) in the absence (▪) or presence (□) of atropine (10−6 M). Incubating the tissues with atropine (10−6 M) attenuated the contractile effect of KCl (A, open squares). Contractions are expressed as a percentage of the response to 60 mM KCl. Data are presented as mean ± SE, n = 6. *p<0.05, **p<0.01, ***p<0.0001, Student’s t-test.

https://doi.org/10.1371/journal.pone.0045340.s001

(TIF)

Figure S2.

The effects of conventional Cl-transport inhibitors on airway smooth muscles contraction evoked by 60 mM KCl. Contractions are expressed as a percentage of the response to 60 mM KCl. Data are presented as mean ± SE, n = 4. *p<0.05, ***p<0.0001, Student’s t-test.

https://doi.org/10.1371/journal.pone.0045340.s002

(TIF)

Figure S3.

Contractile responses of isolated rat trachea rings to bradykinin (A), endothelin-1 (B) and histamine (C). Contractions are expressed as a percentage of the response to 60 mM KCl. Data are presented as mean ± SE, n = 4.

https://doi.org/10.1371/journal.pone.0045340.s003

(TIF)

Acknowledgments

We thank Mr. Godfrey Man for excellent technical assistance.

Author Contributions

Conceived and designed the experiments: KHY JCWM SWSL PV. Performed the experiments: KHY. Analyzed the data: KHY JCWM. Contributed reagents/materials/analysis tools: SWSL DY PV. Wrote the paper: KHY JCWM PV.

References

  1. 1. Gokel GW, Carasel IA (2007) Biologically active, synthetic ion transporters. Chem Soc Rev 36: 378–389.
  2. 2. Fyles TM (2007) Synthetic ion channels in bilayer membranes. Chem Soc Rev 36: 335–347.
  3. 3. Sisson AL, Shah MR, Bhosale S, Matile S (2006) Synthetic ion channels and pores (2004–2005). Chem Soc Rev 35: 1269–1286.
  4. 4. Matile S, Vargas Jentzsch A, Montenegro J, Fin A (2011) Recent synthetic transport systems. Chemical Soc Rev.
  5. 5. Fernandez-Lopez S, Kim HS, Choi EC, Delgado M, Granja JR, et al. (2001) Antibacterial agents based on the cyclic D,L-alpha-peptide architecture. Nature 412: 452–455.
  6. 6. Leevy WM, Donato GM, Ferdani R, Goldman WE, Schlesinger PH, et al. (2002) Synthetic hydraphile channels of appropriate length kill Escherichia coli. J Am Chem Soc 124: 9022–9023.
  7. 7. Dartois V, Sanchez-Quesada J, Cabezas E, Chi E, Dubbelde C, et al. (2005) Systemic antibacterial activity of novel synthetic cyclic peptides. Antimicrob Agents Chemother 49: 3302–3310.
  8. 8. Atkins JL, Patel MB, Cusumano Z, Gokel GW (2010) Enhancement of antimicrobial activity by synthetic ion channel synergy. Chem Commun (Camb) 46: 8166–8167.
  9. 9. Wallace DP, Tomich JM, Eppler JW, Iwamoto T, Grantham JJ, et al. (2000) A synthetic channel-forming peptide induces Cl(–) secretion: modulation by Ca(2+)-dependent K(+) channels. Biochim Biophys Acta 1464: 69–82.
  10. 10. Jiang C, Lee ER, Lane MB, Xiao YF, Harris DJ, et al. (2001) Partial correction of defective Cl(-) secretion in cystic fibrosis epithelial cells by an analog of squalamine. Am J Physiol Lung Cell Mol Physiol 281: L1164–1172.
  11. 11. Broughman JR, Mitchell KE, Sedlacek RL, Iwamoto T, Tomich JM, et al. (2001) NH(2)-terminal modification of a channel-forming peptide increases capacity for epithelial anion secretion. Am J Physiol Cell Physiol 280: C451–458.
  12. 12. Broughman JR, Brandt RM, Hastings C, Iwamoto T, Tomich JM, et al. (2004) Channel-forming peptide modulates transepithelial electrical conductance and solute permeability. Am J Physiol Cell Physiol 286: C1312–1323.
  13. 13. Li X, Shen B, Yao XQ, Yang D (2007) A Small synthetic molecule forms chloride channels to mediate chloride transport across cell membranes. J Am Chem Soc 129: 7264–7265.
  14. 14. Li X, Shen B, Yao XQ, Yang D (2009) Synthetic chloride channel regulates cell membrane potentials and voltage-gated calcium channels. J Am Chem Soc 131: 13676–13680.
  15. 15. Mizuta K, Xu D, Pan Y, Comas G, Sonett JR, et al. (2008) GABAA receptors are expressed and facilitate relaxation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 294: L1206–1216.
  16. 16. Gallos G, Gleason NR, Zhang Y, Pak SW, Sonett JR, et al. (2008) Activation of endogenous GABAA channels on airway smooth muscle potentiates isoproterenol-mediated relaxation. Am J Physiol Lung Cell Mol Physiol 295: L1040–1047.
  17. 17. Gleason NR, Gallos G, Zhang Y, Emala CW (2009) The GABAA agonist muscimol attenuates induced airway constriction in guinea pigs in vivo. J Appl Physiol 106: 1257–1263.
  18. 18. Yim PD, Gallos G, Xu D, Zhang Y, Emala CW (2011) Novel expression of a functional glycine receptor chloride channel that attenuates contraction in airway smooth muscle. FASEB J.
  19. 19. Chipperfield AR, Harper AA (2000) Chloride in smooth muscle. Prog Biophys Mol Biol 74: 175–221.
  20. 20. Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57: 411–425.
  21. 21. Meir A, Ginsburg S, Butkevich A, Kachalsky SG, Kaiserman I, et al. (1999) Ion channels in presynaptic nerve terminals and control of transmitter release. Physiol Rev 79: 1019–1088.
  22. 22. Barnes PJ, Chung KF, Page CP (1998) Inflammatory mediators of asthma: an update. Pharmacol Rev 50: 515–596.
  23. 23. Teixeira MC, Coelho RR, Leal-Cardoso JH, Criddle DN (2000) Comparative effects of niflumic acid and nifedipine on 5-hydroxytryptamine- and acetylcholine-induced contraction of the rat trachea. Eur J Pharmacol 394: 117–122.
  24. 24. Shcheynikov N, Kim KH, Kim KM, Dorwart MR, Ko SB, et al. (2004) Dynamic control of cystic fibrosis transmembrane conductance regulator Cl(-)/HCO3(-) selectivity by external Cl(-). J Biol Chem 279: 21857–21865.
  25. 25. Ishiguro H, Steward MC, Naruse S, Ko SB, Goto H, et al. (2009) CFTR functions as a bicarbonate channel in pancreatic duct cells. J Gen Physiol 133: 315–326.
  26. 26. Ko SB, Shcheynikov N, Choi JY, Luo X, Ishibashi K, et al. (2002) A molecular mechanism for aberrant CFTR-dependent HCO(3)(-) transport in cystic fibrosis. EMBO J 21: 5662–5672.
  27. 27. Hartzell C, Putzier I, Arreola J (2005) Calcium-activated chloride channels. Annu Rev Physiol 67: 719–758.
  28. 28. Barnes PJ (1998) Pharmacology of airway smooth muscle. Am J Respir Crit Care Med 158: S123–132.
  29. 29. Bourreau JP, Kwan CY, Daniel EE (1993) Distinct pathways to refill ACh-sensitive internal Ca2+ stores in canine airway smooth muscle. Am J Physiol 265: C28–35.
  30. 30. Janssen LJ, Sims SM (1992) Acetylcholine activates non-selective cation and chloride conductances in canine and guinea-pig tracheal myocytes. J Physiol 453: 197–218.
  31. 31. Janssen LJ, Sims SM (1993) Histamine activates Cl- and K+ currents in guinea-pig tracheal myocytes: convergence with muscarinic signalling pathway. J Physiol 465: 661–677.
  32. 32. Janssen LJ (2002) Ionic mechanisms and Ca(2+) regulation in airway smooth muscle contraction: do the data contradict dogma? Am J Physiol Lung Cell Mol Physiol 282: L1161–1178.
  33. 33. Bourreau JP, Abela AP, Kwan CY, Daniel EE (1991) Acetylcholine Ca2+ stores refilling directly involves a dihydropyridine-sensitive channel in dog trachea. Am J Physiol 261: C497–505.
  34. 34. Janssen LJ, Sims SM (1993) Emptying and refilling of Ca2+ store in tracheal myocytes as indicated by ACh-evoked currents and contraction. Am J Physiol 265: C877–886.
  35. 35. Coburn RF, Yamaguchi T (1977) Membrane potential-dependent and-independent tension in the canine tracheal muscle. J Pharmacol Exp Ther 201: 276–284.
  36. 36. Farley JM, Miles PR (1977) Role of depolarization in acetylcholine-induced contractions of dog trachealis muscle. J Pharmacol Exp Ther 201: 199–205.
  37. 37. Ito Y, Suzuki H, Aizawa H, Hakoda H, Hirose T (1989) The spontaneous electrical and mechanical activity of human bronchial smooth muscle: its modulation by drugs. Br J Pharmacol 98: 1249–1260.
  38. 38. Ito Y, Takagi K, Tomita T (1995) Relaxant actions of isoprenaline on guinea-pig isolated tracheal smooth muscle. Br J Pharmacol 116: 2738–2742.
  39. 39. Kamei K, Nabata H, Kuriyama H, Watanabe Y, Itoh T (1995) Effect of KC399, a newly synthesized K+ channel opener, on acetylcholine-induced electrical and mechanical activities in rabbit tracheal smooth muscle. Br J Pharmacol 115: 1493–1501.
  40. 40. Souhrada M, Souhrada JF (1993) Effect of IgG1 and its fragments on resting membrane potential of isolated tracheal myocytes. J Appl Physiol 74: 1948–1953.
  41. 41. Janssen LJ (1997) T-type and L-type Ca2+ currents in canine bronchial smooth muscle: characterization and physiological roles. Am J Physiol 272: C1757–1765.
  42. 42. Kotlikoff MI (1988) Calcium currents in isolated canine airway smooth muscle cells. Am J Physiol 254: C793–801.
  43. 43. Marthan R, Martin C, Amedee T, Mironneau J (1989) Calcium channel currents in isolated smooth muscle cells from human bronchus. J Appl Physiol 66: 1706–1714.
  44. 44. Worley JF, 3rd, Kotlikoff MI (1990) Dihydropyridine-sensitive single calcium channels in airway smooth muscle cells. Am J Physiol 259: L468–480.
  45. 45. Hoppe M, Harman E, Hendeles L (1992) The effect of inhaled gallopamil, a potent calcium channel blocker, on the late-phase response in subjects with allergic asthma. J Allergy Clin Immunol 89: 688–695.
  46. 46. Barnes PJ (1985) Clinical studies with calcium antagonists in asthma. Br J Clin Pharmacol 20 Suppl 2289S–298S.